Condition
Heavy Menstrual Bleeding clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Heavy Menstrual Bleeding clinical trials that are recruiting, at sites in 3 countries (most in United States (3), China (1), Switzerland (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Heavy Menstrual Bleeding clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| tAN to reduce heavy menstrual bleeding (LUNA) | — | Boston, Massachusetts | Recruiting | Jan 8, 2026 |
| Managing heavy menstrual bleeding in adolescents with hormonal treatments | — | Geneva | Recruiting | Dec 18, 2024 |
| Relugolix treatment for heavy menstrual bleeding from uterine fibroids | Phase 3 | Beijing | Recruiting | Nov 4, 2024 |
| Registry to collect real-world data on the Cerene Cryotherapy Device | — | West Orange, New Jersey and 1 other locations | Recruiting | Jun 28, 2023 |
| Progestin options for heavy periods in young people with inherited bleeding disorders | — | Palo Alto, California and 7 other locations | Recruiting | Jun 23, 2023 |
All recruiting trials (5)
-
tAN to reduce heavy menstrual bleeding (LUNA)
This trial tests whether transcutaneous auricular neurostimulation (tAN) can reduce heavy menstrual bleeding in people aged 14–45 with no known structural cause.
-
Managing heavy menstrual bleeding in adolescents with hormonal treatments
This study is testing how well hormonal treatments can help teenagers with heavy menstrual bleeding, whether or not they have bleeding disorders.
-
Relugolix treatment for heavy menstrual bleeding from uterine fibroids
This trial will test whether taking relugolix 40 mg once daily can reduce heavy menstrual bleeding in premenopausal women with uterine fibroids compared with placebo.
-
Registry to collect real-world data on the Cerene Cryotherapy Device
This study is collecting information from women who are using the Cerene Cryotherapy Device to treat heavy menstrual bleeding to see how well it works in real life compared to clinical studies.
-
Progestin options for heavy periods in young people with inherited bleeding disorders
This project will test two progestin menstrual treatments—a levonorgestrel IUD and daily norethindrone acetate—in adolescents and young adults (ages 10–24) with inherited bleeding disorders to see which better reduces heavy menstrual bleeding over six months.
Related topics
Quick answers
How many Heavy Menstrual Bleeding clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), China (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.